EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacokinetic Interaction of Kratom and Cannabidiol in Male Rats

Erin C Berthold, Shyam H Kamble iD, Siva Rama Raju Kanumuri iD, Michelle A Kuntz, Alexandria S Senetra iD, Yi-Hua Chiang iD, Sushobhan Mukhopadhyay, Christopher R McCurdy iD, Abhisheak Sharma iD

Pharmaceutics · 24.02.2024 · 16 (3) · 318

DOI: 10.3390/pharmaceutics16030318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 24.02.2024. Verfasst von Erin C Berthold und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Florida, UF Office of the Provost, UF Office of Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kratom and cannabidiol products are used to self-treat a variety of conditions, including anxiety and pain, and to elevate mood. Research into the individual pharmacokinetic properties of commercially available kratom and cannabidiol products has been performed, but there are no studies on coadministration of these products. Surveys of individuals with kratom use history indicate that cannabidiol use is one of the strongest predictors of both lifetime and past month kratom use. The purpose of this study was to determine if there are changes in pharmacokinetic properties when commercially available kratom and cannabidiol products are administered concomitantly. It was found that with concomitant administration of cannabidiol, there was a 2.8-fold increase in the exposure of the most abundant kratom alkaloid, mitragynine, and increases in the exposure of other minor alkaloids. The results of this work suggest that with cannabidiol coadministration, the effects of kratom may be both delayed and increased due to a delay in time to reach maximum plasma concentration and higher systemic exposure of the psychoactive alkaloids found in kratom.

Schlagwörter

Stichwörter der Autor:innen

cannabidiolkratommitragyninepharmacokinetic interactions

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
  • Translational Drug Development Core, University of Florida Clinical and Translational Science Institute, Gainesville, FL 32610, USA.
  • Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.

ORCID-Profile: Shyam H Kamble, Siva Rama Raju Kanumuri, Alexandria S Senetra, Yi-Hua Chiang, Christopher R McCurdy, Abhisheak Sharma

Förderung

  • University of Florida
  • UF Office of the Provost
  • UF Office of Research
  • UF Health
  • UF College of Medicine
  • UF Clinical and Translational Science Institute

Zitieren

APA

Berthold, E. C., Kamble, S. H., Kanumuri, S. R. R., Kuntz, M. A., Senetra, A. S., Chiang, Y. H., Mukhopadhyay, S., McCurdy, C. R., & Sharma, A. (2024). Pharmacokinetic Interaction of Kratom and Cannabidiol in Male Rats. Pharmaceutics, 16(3), 318. https://doi.org/10.3390/pharmaceutics16030318

Vancouver

Berthold EC, Kamble SH, Kanumuri SRR, Kuntz MA, Senetra AS, Chiang YH, et al. Pharmacokinetic Interaction of Kratom and Cannabidiol in Male Rats. Pharmaceutics. 2024;16(3):318. doi:10.3390/pharmaceutics16030318

BibTeX
@article{Berthold2024,
  author = {Berthold, Erin C and Kamble, Shyam H and Kanumuri, Siva Rama Raju and Kuntz, Michelle A and Senetra, Alexandria S and Chiang, Yi-Hua and Mukhopadhyay, Sushobhan and McCurdy, Christopher R and Sharma, Abhisheak},
  title = {Pharmacokinetic Interaction of Kratom and Cannabidiol in Male Rats},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {3},
  pages = {318},
  doi = {10.3390/pharmaceutics16030318}
}
Kostenlos starten →